Dr. Ai on the Efficacy of Brentuximab Vedotin in Patients With Advanced Cutaneous T-Cell Lymphoma
5 Visninger
• 08/09/23
0
0
Indlejre
administrator
Abonnenter
Weiyun Z. Ai, MD, PhD, assistant clinical professor, Department of Medicine, University of California San Francisco, discusses the scenarios in which she has seen the most benefit from brentuximab vedotin (Adcetris) in patients with advanced stage cutaneous T-cell lymphoma (CTCL).
Vis mere
Facebook kommentarer
SORT BY-
Topkommentarer
-
Seneste kommentarer